These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23664005)

  • 21. Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction.
    Casey KF; Benkelfat C; Cherkasova MV; Baker GB; Dagher A; Leyton M
    Biol Psychiatry; 2014 Jul; 76(1):23-30. PubMed ID: 24138922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging receptor changes in human drug abusers.
    Cosgrove KP
    Curr Top Behav Neurosci; 2010; 3():199-217. PubMed ID: 21161754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic system dysfunction in recreational dexamphetamine users.
    Schrantee A; Václavů L; Heijtel DF; Caan MW; Gsell W; Lucassen PJ; Nederveen AJ; Booij J; Reneman L
    Neuropsychopharmacology; 2015 Mar; 40(5):1172-80. PubMed ID: 25394786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron Emission Tomography: Updates on Imaging of Addiction.
    Solingapuram Sai JKK; Hurley RA; Dodda M; Taber KH
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):A6-288. PubMed ID: 31613195
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food and drug reward: overlapping circuits in human obesity and addiction.
    Volkow ND; Wang GJ; Fowler JS; Tomasi D; Baler R
    Curr Top Behav Neurosci; 2012; 11():1-24. PubMed ID: 22016109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarities and Differences in Neuroimaging.
    Sun YK; Sun Y; Lin X; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults.
    Oswald LM; Wand GS; Wong DF; Brown CH; Kuwabara H; Brašić JR
    Neuroimage; 2015 Jun; 113():26-36. PubMed ID: 25795343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
    Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ
    J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heightened Dopaminergic Response to Amphetamine at the D
    Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ
    Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.
    Ersche KD; Williams GB; Robbins TW; Bullmore ET
    Curr Opin Neurobiol; 2013 Aug; 23(4):615-24. PubMed ID: 23523373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography neuroimaging for a better understanding of the biology of ADHD.
    Zimmer L
    Neuropharmacology; 2009 Dec; 57(7-8):601-7. PubMed ID: 19682469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine and stimulant addiction.
    Sofuoglu M; Sewell RA
    Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging of opioid receptors in the central nervous system.
    Henriksen G; Willoch F
    Brain; 2008 May; 131(Pt 5):1171-96. PubMed ID: 18048446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights from recent positron emission tomographic studies of drug abuse and dependence.
    Chang L; Haning W
    Curr Opin Psychiatry; 2006 May; 19(3):246-52. PubMed ID: 16612209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addiction.
    Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ
    Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.